Single use Bioprocessing Market

Single use Bioprocessing Market by Product (Media Bags and containers, Bioreactors, Mixers, Assemblies), Application (Cell Culture, Mixing, Storage, Filtration, Purification), End User (Biopharma Companies, CROs, CMOs) - Global Forecast 2026

Report Code: BT 4630 Aug, 2021, by marketsandmarkets.com

[369 Pages Report] The global single-use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5% during the forecast period. Factors such as the increasing demand for biopharmaceuticals & energy efficiency; the need to reduce water wastage, equipment floor space requirement, and the risk of cross-contamination are the key factors driving the growth of the single-use bioprocessing market. However, extractability and leachability issues regarding disposable components and environmental & economic concerns are the major factors restraining market growth.

Single-use Bioprocessing Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the Single use Bioprocessing Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has since moved from being a regional crisis to a global pandemic. With the World Health Organization (WHO) officially declared the virus outbreak as a pandemic, a mix of established pharmaceutical companies and small startups had stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.

Many biopharmaceutical companies have been rapidly developing vaccines in response to the novel coronavirus pandemic. If these development programs pass the trial phases, the clinical and commercial manufacturing platforms will be largely supported by single-use equipment and systems. Since most of the leading COVID-19 vaccine programs use novel approaches, including mRNA, DNA vaccine, and vectors, these platforms are largely built on single-use systems. Single-use systems are flexible and can quickly be put in place at a lower cost than traditional stainless-steel equipment, which has significant investments and no guarantee of longevity for the future.

In the race to develop a vaccine against the coronavirus, many leading manufacturers of single-use bioprocessing systems are currently working with companies with a vaccine in development or already in the clinical test phases. For instance, Sartorius supplies cell culture media, bioreactors, special filters, and analytical instruments for developing and manufacturing vaccines, among other things. The company has supported CanSino Biologics Inc. and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences in China developed the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials. They used Sartorius’ BIOSTAT STR single-use bioreactor system for the upstream preparation of the recombinant vaccine, ensuring the rapid linear amplification of the adenovirus vector (Ad5-nCoV) and ultimately saving time during development. This, in a way, has led to a positive impact on the single-use bioprocessing market.

Global Single use Bioprocessing Market Dynamics

DRIVER: The growing demand for biopharmaceuticals

According to the UN Ageing population highlights, in 2020, an estimated 727 million individuals of the global population was aged 65 years and older; by 2050, this figure is estimated to double and reach 1.5 billion individuals. With a growth in the senior population across major markets, the demand for biopharmaceuticals is expected to increase as the elderly are more prone to chronic conditions & diseases. To cater to the growing demand for biopharmaceuticals, companies are increasingly preferring single-use bioprocessing systems as they increase process efficiency and decrease the costs associated with complicated steps like cleaning, sterilization, and maintenance of steel-based bioreactor systems. Single-use bioprocessing technology is used in a broad range of biopharmaceutical applications, including filtration, mixing, purification, upstream expression, storage, and separation. Hence, the increasing demand for biopharmaceuticals is majorly contributing to the growth of the single-use bioprocessing market.

RESTRAINT: Issues related to leachables and extractables

Specific guidelines or regulations regarding the contamination of single-use bioprocessing systems due to extractables and leachables are not yet established. However, a complete list of tests that can be performed for single-use systems has been published by the Bio-Process Systems Alliance (BPSA). Extractables can be extracted from source materials using appropriate solvents under vigorous laboratory conditions. At the same time, leachables are compounds present in drug products caused by leaching from containers, closures, and processing components. Therefore, leachables can be considered as a subset of extractable. These leachables and extractables are udesired products. As single-use bioprocessing products are made of processed plastic materials, they often face contamination from the container due to leachables. Thus, significant concerns regarding extractables and leachables arising from the components of single-use bioprocessing systems may hinder the market growth owing to their potential effects on product quality and patient health.

OPPORTUNITY: Emerging markets

In the Asian region, China is a high-potential market for single-use bioprocessing systems, followed by India. This can majorly be attributed to the presence of favorable government support, rising private investments, growing geriatric population, rising trend of outsourcing to emerging Asian markets, and presence of a skilled workforce in these countries. India, Japan, Brazil, and RoAPAC are expected to be the new revenue pockets for market players. Also, the high investment in bio-manufacturing infrastructure is a key factor responsible for the high-growth potential of these markets. For instance, in March 2021, Thermo Fisher Scientific announced a USD 600 million investment to expand its bioprocessing capabilities. This investment was made to meet increasing demands for vaccine and biologics production.

CHALLENGE: Waste disposal

Biopharmaceutical companies are increasingly adopting single-use bioprocessing systems considering the several associated advantages, such as cost reduction, faster process development time, and lower capital investments. However, there still are serious concerns related to the disposal of solid waste materials from this alternative technology. Recycling is not an option for such products because they require extensive efforts to separate the components into homogeneous components. As a result, most single-use systems and their components are not suited for recycling.

The Single-use Media Bags and Containers segment dominated the Single Use Bioprocessing Market in 2020:

Based on product, the single-use bioprocessing market is categorized into single-use media bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, and other products.

The other products segment includes single-use vessels, tubing, connectors. In 2020, the single-use media bags and containers segment accounted for the largest share of the global single-use bioprocessing market by product. The expanded application of single-use bags across biomanufacturing processes drives the market for single-use media bags. Single-use bioprocessing systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharmaceutical applications.

The filtration segment accounted for the largest share in 2020

The global single-use bioprocessing market is categorized into five segments based on applications: filtration, mixing, purification, storage, and cell culture. In 2020, the filtration segment accounted for the largest share of the global single-use bioprocessing market followed by storage application.

Single-use Bioprocessing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for Single use Bioprocessing Market in 2020.

The single-use bioprocessing market is divided into five major regions—North America, Europe, Asia Pacific, Latin America (LATAM), and the Middle East and Africa (MEA). North America accounted for the largest share of this market, followed by Europe in 2020. The increasing demand for biopharmaceuticals is a major factor driving the single-use bioprocessing market in North America. The demand for biopharmaceuticals is rising owing to the growing senior population. The rising demand for biopharmaceuticals and advantages of single-use bioprocessing (such as high energy efficiency, low water usage, less floor space requirement, reduced installation cost, decreased risk of product cross-contamination, and fast implementation) drive the adoption of the single-use bioprocessing market. On the other hand, the high disposable cost and issues related to the transfer of leachables and extractables into the solvent, which can cause contamination, are the major factors restraining the growth of this market.

Key Market Players

Key players in the single use bioprocessing market include Sartorius Stedim Biotech S.A. (France), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), and Merck KGaA (Germany).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Product, Application, End user and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)

Companies covered

Sartorius Stedim Biotech S.A.  (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Getinge AB (Sweden), Eppendorf AG (Germany), Corning (US), Entegris (US), Avantor (US), CESCO Bioengineering Co. Ltd. (Taiwan), Cellexus (UK), PBS Biotech, Inc. (US), Distek, Inc. (US), ABEC, Inc. (US), Able Corporation & Biott Corporation (Japan), G&G Technologies (US), Solida Biotech GmbH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Stobbe Pharma GmbH (Switzerland), Celltainer Biotech (Netherlands), Meissner Filtration Products, Inc. (US), bbi-biotech GmbH (Germany), Pierre Guerin (France), Kuhner AG (Switzerland), OmniBRx Biotechnologies (India).

This report categorizes the single use bioprocessing market into the following segments and subsegments:

Single use Bioprocessing Market, by Product

  • Single-use media bags and containers
  • Single-use assemblies
  • Single-use bioreactors
  • Disposable mixers
  • Other products

Single use Bioprocessing Market, by Application

  • Filtration
  • Storage
  • Cell culture
  • Mixing
  • Purification

Single use Bioprocessing Market, by End user

  • Biopharmaceutical & Pharmaceutical companies
  • Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
  • Academic & Research institutes

Single use Bioprocessing Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Recent Developments

  • In March 2020, Danaher acquired the Biopharma business from General Electric Company's Life Sciences division. The business is called Cytiva, and is a standalone operating company within Danaher's Life Sciences segment.
  • In September 2020, Thermo Fisher Scientific invested more than USD 475 million in new capabilities at its St. Louis site to expand biologics development and manufacturing, cell and gene therapy capabilities, and drug product development capabilities.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 29)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 32)
    2.1 RESEARCH METHODOLOGY
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY SOURCES: SINGLE-USE BIOPROCESSING MARKET
    2.2 MARKET SIZE ESTIMATION
           FIGURE 2 MARKET SIZE ESTIMATION APPROACH: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
           FIGURE 3 SINGLE-USE BIOPROCESSING MARKET: FINAL MARKET (USD BILLION)
           FIGURE 4 BREAKDOWN OF PRIMARIES: SINGLE-USE BIOPROCESSING MARKET
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY
           2.3.1 KEY INDUSTRY INSIGHTS
           2.3.2 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 40)
    FIGURE 6 MEDIA BAGS AND CONTAINERS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
    FIGURE 7 FILTRATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET DURING THE FORECAST PERIOD
    FIGURE 8 CROS AND CMOS TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET DURING THE FORECAST PERIOD
    FIGURE 9 GEOGRAPHICAL SNAPSHOT: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET IN 2020

4 PREMIUM INSIGHTS (Page No. - 43)
    4.1 SINGLE-USE BIOPROCESSING MARKET OVERVIEW, 2021 VS. 2026
           FIGURE 10 RISING DEMAND FOR BIOPHARMACEUTICALS IS A KEY DRIVER FOR MARKET GROWTH
    4.2 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET,  BY PRODUCT & COUNTRY (2021)
           FIGURE 11 MEDIA BAGS AND CONTAINERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021
    4.3 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION
           FIGURE 12 THE FILTRATION SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET IN 2020
    4.4 SINGLE-USE BIOPROCESSING MARKET, BY END USER
           FIGURE 13 BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE END USERS SEGMENT IN 2020

5 MARKET OVERVIEW (Page No. - 46)
    5.1 INTRODUCTION
           FIGURE 14 SINGLE-USE BIOPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.1.1 DRIVERS
                    5.1.1.1 The growing demand for biopharmaceuticals
                    5.1.1.2 Reduced investments for single-use bioprocessing technologies
                               FIGURE 15 IMPACT ON VARIOUS PARAMETERS: SINGLE-USE SYSTEMS VS. STAINLESS STEEL SYSTEMS
                    5.1.1.3 Faster implementation and lower risk of product cross-contamination
           5.1.2 RESTRAINTS
                    5.1.2.1 Issues related to leachables and extractables
                               TABLE 1 KEY EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS
           5.1.3 OPPORTUNITIES
                    5.1.3.1 Emerging markets
                    5.1.3.2 Patent Expiry
                               FIGURE 16 US: BIOLOGICS GOING OFF-PATENT IN THE COMING YEARS
           5.1.4 CHALLENGES
                    5.1.4.1 Waste disposal
                               TABLE 2 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
                    5.1.4.2 Issues associated with scalability
    5.2 PORTER’S FIVE FORCES ANALYSIS
           FIGURE 17 PORTER’S FIVE FORCES ANALYSIS (2020)
           5.2.1 THREAT FROM NEW ENTRANTS
           5.2.2 THREAT FROM SUBSTITUTES
           5.2.3 BARGAINING POWER OF SUPPLIERS
           5.2.4 BARGAINING POWER OF BUYERS
           5.2.5 INTENSITY OF COMPETITIVE RIVALRY
    5.3 VALUE CHAIN ANALYSIS
           FIGURE 18 VALUE CHAIN ANALYSIS OF THE ECOSYSTEM OF SINGLE-USE BIOPROCESSING: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
    5.4 PRICING ANALYSIS
           TABLE 3 AVERAGE SELLING PRICE OF SINGLE-USE BIOREACTORS BY REGION (2019)
    5.5 TECHNOLOGICAL ANALYSIS
    5.6 IMPACT OF COVID-19 OUTBREAK ON THE SINGLE-USE BIOPROCESSING MARKET

6 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT (Page No. - 59)
    6.1 INTRODUCTION
           TABLE 4 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           TABLE 5 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
    6.2 SINGLE-USE MEDIA BAGS AND CONTAINERS
           6.2.1 EXPANDED APPLICATIONS OF SINGLE-USE BAGS ACROSS BIOPROCESSING OPERATIONS TO DRIVE THE MARKET GROWTH FOR THIS SEGMENT
                    TABLE 6 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 7 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 8 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY,  2017–2020 (USD MILLION)
                    TABLE 9 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY,  2021–2026 (USD MILLION)
                    TABLE 10 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 11 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 12 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY,  2017–2020 (USD MILLION)
                    TABLE 13 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY,  2021–2026 (USD MILLION)
    6.3 SINGLE-USE ASSEMBLIES
           6.3.1 REDUCED RISK OF CONTAMINATION HAS PROPELLED THE DEMAND FOR SINGLE-USE ASSEMBLIES
                    TABLE 14 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 15 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 16 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 17 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 18 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 19 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 20 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 21 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
    6.4 SINGLE-USE BIOREACTORS
           6.4.1 SINGLE-USE BIOREACTOR SYSTEMS OFFER GREAT FLEXIBILITY OF OPERATIONS
                    TABLE 22 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 23 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 24 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 25 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,  2021–2026 (USD MILLION)
                    TABLE 26 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,  2017–2020 (USD MILLION)
                    TABLE 27 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 28 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 29 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
    6.5 DISPOSABLE MIXERS
           6.5.1 DISPOSABLE MIXERS OFFER REDUCED RISK OF CROSS CONTAMINATION WHICH DRIVES THE GROWTH OF THIS SEGMENT
                    TABLE 30 DISPOSABLE MIXERS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 31 DISPOSABLE MIXERS MARKET, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 32 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 33 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY,  2021–2026 (USD MILLION)
                    TABLE 34 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 35 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 36 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 37 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
    6.6 OTHER PRODUCTS
           TABLE 38 OTHER PRODUCTS MARKET, BY REGION, 2017–2020 (USD MILLION)
           TABLE 39 OTHER PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION)
           TABLE 40 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 41 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 42 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 43 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 44 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 45 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)

7 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION (Page No. - 76)
    7.1 INTRODUCTION
           TABLE 46 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
           TABLE 47 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
    7.2 FILTRATION
           TABLE 48 FILTRATION APPLICATION, BY REGION, 2017–2020 (USD MILLION)
           TABLE 49 FILTRATION APPLICATION, BY REGION, 2021–2026 (USD MILLION)
           TABLE 50 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 51 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 52 EUROPE: FILTRATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 53 EUROPE: FILTRATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 54 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 55 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
    7.3 STORAGE
           7.3.1 SINGLE-USE STORAGE SYSTEMS OFFER COST SAVINGS ON STERILIZATION PROCESS
                    TABLE 56 STORAGE APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 57 STORAGE APPLICATION, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 58 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 59 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 60 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 61 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 62 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 63 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
    7.4 CELL CULTURE
           7.4.1 SINGLE-USE CELL CULTURE PRODUCTS OFFER REDUCED RISK OF CONTAMINATION
                    TABLE 64 CELL CULTURE APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 65 CELL CULTURE APPLICATION, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 66 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 67 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 68 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 69 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 70 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 71 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
    7.5 MIXING
           7.5.1 DISPOSABLE MIXING SYSTEMS ARE COST-EFFICIENT, PREVENTING CLEANING AND STERILIZATION CHARGES
                    TABLE 72 MIXING APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 73 MIXING APPLICATION, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 74 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 75 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 76 EUROPE: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 77 EUROPE: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 78 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 79 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
    7.6 PURIFICATION
           7.6.1 SINGLE-USE PURIFICATION PRODUCTS ARE INCREASINGLY IN DEMAND OWING TO FLEXIBILITY OF USE
                    TABLE 80 PURIFICATION APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 81 PURIFICATION APPLICATION, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 82 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 83 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 84 EUROPE: PURIFICATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 85 EUROPE: PURIFICATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 86 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 87 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION)

8 SINGLE-USE BIOPROCESSING MARKET, BY END USER (Page No. - 91)
    8.1 INTRODUCTION
           TABLE 88 SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
           TABLE 89 SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
    8.2 BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES
           8.2.1 INCREASING PHARMACEUTICAL R&D SPENDING IS DRIVING THE DEMAND FOR SINGLE-USE BIOPROCESSING EQUIPMENT IN THIS END-USER SEGMENT
                    TABLE 90 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 91 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 92 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL  & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 93 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 94 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 95 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 96 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 97 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
    8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CONTRACT MANUFACTURING ORGANIZATIONS (CMOS)
           8.3.1 INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT THE MARKET GROWTH OF CROS AND CMOS
                    TABLE 98 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION,  2017–2020 (USD MILLION)
                    TABLE 99 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION,  2021–2026 (USD MILLION)
                    TABLE 100 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS,  BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 101 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS,  BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 102 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY,  2017–2020 (USD MILLION)
                    TABLE 103 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY,  2021–2026 (USD MILLION)
                    TABLE 104 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 105 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2026 (USD MILLION)
    8.4 ACADEMIC & RESEARCH INSTITUTES
           8.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE THE MARKET GROWTH
                    TABLE 106 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY REGION, 2017–2020 (USD MILLION)
                    TABLE 107 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY REGION, 2021–2026 (USD MILLION)
                    TABLE 108 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 109 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 110 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 111 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 112 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 113 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)

9 SINGLE-USE BIOPROCESSING MARKET, BY REGION (Page No. - 103)
    9.1 INTRODUCTION
           FIGURE 19 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
           TABLE 114 SINGLE-USE BIOPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION)
           TABLE 115 SINGLE-USE BIOPROCESSING MARKET, BY REGION, 2021–2026 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 20 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT
           TABLE 116 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY,  2017–2020 (USD MILLION)
           TABLE 117 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY,  2021–2026 (USD MILLION)
           TABLE 118 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,  2017–2020 (USD MILLION)
           TABLE 119 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT,  2021–2026 (USD MILLION)
           TABLE 120 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,  2017–2020 (USD MILLION)
           9.2.1 US
                    9.2.1.1 The growing focus on biopharmaceutical production in the US drives the market growth
                               TABLE 124 US: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 The increasing incidences of lifestyle diseases such as cancer drive the market growth for biologics in Canada
                               TABLE 130 CANADA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
    9.3 EUROPE
           TABLE 136 EUROPE: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Increasing adoption of single-use bioprocessing equipment by biopharma and CDMO companies to drive the market growth
                               TABLE 144 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 145 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                               TABLE 146 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                               TABLE 147 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                               TABLE 148 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 149 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Rising government support for biotech companies to propel the demand for advanced technologies in the UK
                               TABLE 150 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 151 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                               TABLE 152 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                               TABLE 153 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                               TABLE 154 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 155 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Increasing investments in life sciences R&D infrastructure development to drive the market growth in France
                               TABLE 156 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,  2017–2020 (USD MILLION)
                               TABLE 157 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                               TABLE 158 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                               TABLE 159 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                               TABLE 160 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 161 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
           9.3.4 REST OF EUROPE (ROE)
                    TABLE 162 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                    TABLE 163 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                    TABLE 164 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                    TABLE 165 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                    TABLE 166 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                    TABLE 167 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
    9.4 ASIA PACIFIC
           TABLE 168 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           FIGURE 21 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT
           9.4.1 CHINA
                    9.4.1.1 Government support and significant private investments to drive the market growth in China
                               TABLE 176 CHINA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Increasing biomanufacturing investments to favor the market growth
                               TABLE 182 JAPAN: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Low manufacturing and labor costs make India a lucrative country for single-use bioprocessing equipment manufacturers
                               TABLE 188 INDIA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 194 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                    TABLE 195 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                    TABLE 196 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                    TABLE 197 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                    TABLE 198 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                    TABLE 199 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
    9.5 LATIN AMERICA (LATAM)
           9.5.1 BRAZIL ACCOUNTS FOR THE LARGEST SHARE OF THE LATAM REGION FOR SINGLE-USE BIOPROCESSING IN 2020
                    TABLE 200 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                    TABLE 201 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                    TABLE 202 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                    TABLE 203 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                    TABLE 204 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                    TABLE 205 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)
    9.6 MIDDLE EAST AND AFRICA (MEA)
           9.6.1 THE GROWTH OF THE BIOTECHNOLOGY INDUSTRY IN THIS REGION DRIVES THE WIDE ADOPTION OF SINGLE-USE BIOPROCESSING PRODUCTS
                    TABLE 206 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                    TABLE 207 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                    TABLE 208 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                    TABLE 209 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                    TABLE 210 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                    TABLE 211 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 145)
     10.1 MARKET EVALUATION FRAMEWORK
     10.2 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION QUADRANT
             10.2.1 STARS
             10.2.2 EMERGING LEADERS
             10.2.3 PERVASIVE
             10.2.4 PARTICIPANTS
                       FIGURE 22 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION MATRIX, 2020
     10.3 MARKET RANK ANALYSIS
               FIGURE 23 SINGLE-USE BIOPROCESSING MARKET: MARKET RANKING  OF KEY PLAYERS (2020)
     10.4 COMPETITIVE SCENARIO
             10.4.1 KEY PRODUCT LAUNCHES
             10.4.2 KEY ACQUISITIONS
             10.4.3 KEY PARTNERSHIPS AND AGREEMENTS
             10.4.4 KEY EXPANSIONS

11 COMPANY PROFILES (Page No. - 151)
(Business overview, Products offered, Recent Developments,SWOT Analysis, MNM view)*
     11.1 SARTORIUS STEDIM BIOTECH
               TABLE 212 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW
               FIGURE 24 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020)
     11.2 DANAHER CORPORATION
               TABLE 213 DANAHER CORPORATION: BUSINESS OVERVIEW
               FIGURE 25 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
     11.3 THERMO FISHER SCIENTIFIC
               TABLE 214 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
               FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
     11.4 MERCK KGAA
               TABLE 215 MERCK KGAA: BUSINESS OVERVIEW
               FIGURE 27 MERCK KGAA: COMPANY SNAPSHOT (2020)
     11.5 GETINGE AB
               TABLE 216 GETINGE AB: BUSINESS OVERVIEW
               FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2020)
     11.6 EPPENDORF AG
               TABLE 217 EPPENDORF AG: BUSINESS OVERVIEW
               FIGURE 29 EPPENDORF: COMPANY SNAPSHOT (2020)
     11.7 CORNING
               TABLE 218 CORNING: BUSINESS OVERVIEW
               FIGURE 30 CORNING COMPANY SNAPSHOT (2020)
     11.8 ENTEGRIS
               TABLE 219 ENTEGRIS: BUSINESS OVERVIEW
               FIGURE 31 ENTEGRIS COMPANY SNAPSHOT (2020)
     11.9 AVANTOR
               TABLE 220 AVANTOR: BUSINESS OVERVIEW
               FIGURE 32 AVANTOR: COMPANY SNAPSHOT (2020)
     11.10 CESCO BIOENGINEERING CO., LTD.
               TABLE 221 CESCO BIOENGINEERING CO., LTD.: BUSINESS OVERVIEW
     11.11 CELLEXUS
                       TABLE 222 CELLEXUS: BUSINESS OVERVIEW
     11.12 PBS BIOTECH, INC.
                       TABLE 223 PBS BIOTECH, INC.: BUSINESS OVERVIEW
     11.13 DISTEK, INC.
                       TABLE 224 DISTEK, INC.: BUSINESS OVERVIEW
     11.14 ABEC, INC.
                       TABLE 225 ABEC INC.: BUSINESS OVERVIEW
     11.15 ABLE CORPORATION & BIOTT CORPORATION
                       TABLE 226 ABLE CORPORATION & BIOTT CORPORATION: BUSINESS OVERVIEW
     11.16 G&G TECHNOLOGIES, INC.
                       TABLE 227 G&G TECHNOLOGIES INC.: BUSINESS OVERVIEW
     11.17 SOLIDA BIOTECH GMBH
                       TABLE 228 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
     11.18 SATAKE CHEMICAL EQUIPMENT MFG., LTD.
                       TABLE 229 SATAKE CHEMICAL EQUIPMENT MFG. LTD: BUSINESS OVERVIEW
     11.19 STOBBE PHARMA GMBH
                       TABLE 230 STOBBE PHARMA GMBH: BUSINESS OVERVIEW
     11.20 CELLTAINER BIOTECH BV
               TABLE 231 CELLTAINER BIOTECH BV: BUSINESS OVERVIEW
     11.21 MEISSNER FILTRATION PRODUCTS, INC.
                       TABLE 232 MEISSNER FILTRATION PRODUCTS INC.: BUSINESS OVERVIEW
     11.22 BBI-BIOTECH
                       TABLE 233 BBI BIOTECH: BUSINESS OVERVIEW
     11.23 PIERRE GUΙRIN
                       TABLE 234 PIERRE GUERIN: BUSINESS OVERVIEW
     11.24 KUHNER AG
                       TABLE 235 KUHNER AG: BUSINESS OVERVIEW
     11.25 OMNIBRX BIOTECHNOLOGIES

*Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 200)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global single use bioprocessing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess market prospects. The single use bioprocessing market size was estimated through various secondary research approaches and triangulated with inputs from primary research.

Secondary Research

The secondary sources referred to for this research study include publications from government sources [such as the Organisation for Economic Co-operation and Development (OECD), GLOBOCAN, Bio-Process Systems Alliance (BPSA)]; site like bioprocess international, and annual reports; SEC filings; press releases; investor presentations; journals; expert interviews; MarketsandMarkets analysis; business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global single use bioprocessing market, which was validated through primary research.

Primary Research

After acquiring basic knowledge about the global single use bioprocessing market scenario through secondary research, extensive primary research was conducted. Several primary interviews were conducted with market experts from both the demand side (such as personnel from pharmaceutical & biopharmaceutical companies) and the supply side (such as Pharmaceutical and biopharmaceutical manufacturing companies) across major regions namely North America, Europe, the Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews. The following is a breakdown of the primary respondents:

Single-use Bioprocessing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the single use bioprocessing market was estimated through different approaches. A detailed market estimation approach was followed to estimate and validate the global market value and other dependent submarkets, as mentioned below. Both top-down and bottom-up approaches were used to estimate and validate the total size of the single use bioprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the single use bioprocessing business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.  

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global single-use bioprocessing market based on product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall single-use bioprocessing market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments concerning five major regional segments, namely, North America, Europe, the Asia Pacific, Latin America (LATAM), and the Middle East & Africa (MEA)
  • To profile key players in the market and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, agreements expansions in the single-use bioprocessing market.

Available Customizations

With the given market data, MarketsandMar kets offers customizations as per the company’s specific needs. The following customization options are available for this report:

COVID-19

Get in-depth analysis of the COVID-19 impact on the Single use Bioprocessing Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Single use Bioprocessing Market

Request For Special Pricing
Report Code
BT 4630
Published ON
Aug, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Single use Bioprocessing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved